Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Meizoso, Jonathan
DATE, NCT05545735: The Duration of Antibiotic Therapy for Early () Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days	Recruiting	4	458	US	Standard of Care Antibiotic Therapy	University of Miami	Ventilator Associated Pneumonia	06/25	06/25
NCT05156983 / 2021-004138-12: A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery	Recruiting	3	328	Europe, Canada, US	TAK-330, SOC 4F-PCC	Takeda, Takeda Development Center Americas, Inc.	Coagulation Disorder	04/28	04/28